A PILOT STUDY TO ASSESS PATIENTS' COMFORT LEVEL WHILE UNDERGOING INTRAPERITONEAL CHEMOTHERAPY WITH THE USE OF WARMING INTERVENTIONS.

2.50
Hdl Handle:
http://hdl.handle.net/10755/164910
Category:
Abstract
Type:
Presentation
Title:
A PILOT STUDY TO ASSESS PATIENTS' COMFORT LEVEL WHILE UNDERGOING INTRAPERITONEAL CHEMOTHERAPY WITH THE USE OF WARMING INTERVENTIONS.
Author(s):
Whyte, Darlene
Author Details:
Darlene Whyte, RN, BN, Clinical Educator, Tom Baker Cancer Center, Calgary, Alberta, Canada, email: gdwhyte@telusplanet.net
Abstract:
Ovarian epithelial carcinoma causes more deaths than any other cancer of the female reproductive system. Women with advanced ovarian cancer who are optimally debulked have the opportunity to significantly increase survival if their chemotherapy is administered via the intraperitoneal (IP) route as compared to the intravenous (IV) route after debulking surgery. An extensive literature search could not provide evidence to suggest that specific warming interventions improve the patients comfort while undergoing intraperitoneal chemotherapy. Patient comfort levels could adversely affect the number of chemotherapy cycle that the patient can tolerate and therefore, could affect patient outcomes. The objective of this study is to explore warming interventions during intraperitoneal chemotherapy and examine the impact on patient comfort. Oncology nurses have an obligation to provide high quality, safe, compassionate care in accordance with best practice/evidence- based guidelines. This obligation includes optimizing quality of life and promoting the best possible patient experience. Oncology nurses have the opportunity to positively influence patientsÆ experiences and mitigate the potential adverse side effects/experiences that patients may encounter. Providing the most comfortable method of IP treatment may influence the number of cycles of chemotherapy the patient chooses to complete. Exploring the use of select nursing interventions while patients are undergoing intraperitoneal chemotherapy will provide insight as to the patient experience as well as assess the efficacy of the aforementioned warming interventions. Patients are selected for one of 3 arms. In Arm 1 the patient receives intraperitoneal chemotherapy warmed to body temperature. In Arm 2 the patient receives intraperitoneal chemotherapy at room temperature but will apply a heating pad to the abdomen. In Arm 3 the patient receives intraperitoneal chemotherapy at room temperature. The patient completes baseline European Organization for Treatment of Cancer Quality of Life C30 (EORTC QLQ-C30) and OV 28 (EORTC QLQ OV 28) forms prior to treatment and following each IP chemotherapy infusion. Descriptive statistics will be computed for all variables (including mean, standard deviation, median and range). T-tests will be used to assess differences between groups. Research is in progress, no preliminary findings available.
Repository Posting Date:
27-Oct-2011
Date of Publication:
27-Oct-2011
Conference Date:
2007
Conference Name:
32nd Annual Oncology Nursing Society Congress
Conference Host:
Oncology Nursing Society
Conference Location:
Las Vegas, Nevada, USA
Note:
This is an abstract-only submission. If the author has submitted a full-text item based on this abstract, you may find it by browsing the Virginia Henderson Global Nursing e-Repository by author. If author contact information is available in this abstract, please feel free to contact him or her with your queries regarding this submission. Alternatively, please contact the conference host, journal, or publisher (according to the circumstance) for further details regarding this item. If a citation is listed in this record, the item has been published and is available via open-access avenues or a journal/database subscription. Contact your library for assistance in obtaining the as-published article.

Full metadata record

DC FieldValue Language
dc.type.categoryAbstracten_US
dc.typePresentationen_GB
dc.titleA PILOT STUDY TO ASSESS PATIENTS' COMFORT LEVEL WHILE UNDERGOING INTRAPERITONEAL CHEMOTHERAPY WITH THE USE OF WARMING INTERVENTIONS.en_GB
dc.contributor.authorWhyte, Darleneen_US
dc.author.detailsDarlene Whyte, RN, BN, Clinical Educator, Tom Baker Cancer Center, Calgary, Alberta, Canada, email: gdwhyte@telusplanet.neten_US
dc.identifier.urihttp://hdl.handle.net/10755/164910-
dc.description.abstractOvarian epithelial carcinoma causes more deaths than any other cancer of the female reproductive system. Women with advanced ovarian cancer who are optimally debulked have the opportunity to significantly increase survival if their chemotherapy is administered via the intraperitoneal (IP) route as compared to the intravenous (IV) route after debulking surgery. An extensive literature search could not provide evidence to suggest that specific warming interventions improve the patients comfort while undergoing intraperitoneal chemotherapy. Patient comfort levels could adversely affect the number of chemotherapy cycle that the patient can tolerate and therefore, could affect patient outcomes. The objective of this study is to explore warming interventions during intraperitoneal chemotherapy and examine the impact on patient comfort. Oncology nurses have an obligation to provide high quality, safe, compassionate care in accordance with best practice/evidence- based guidelines. This obligation includes optimizing quality of life and promoting the best possible patient experience. Oncology nurses have the opportunity to positively influence patientsÆ experiences and mitigate the potential adverse side effects/experiences that patients may encounter. Providing the most comfortable method of IP treatment may influence the number of cycles of chemotherapy the patient chooses to complete. Exploring the use of select nursing interventions while patients are undergoing intraperitoneal chemotherapy will provide insight as to the patient experience as well as assess the efficacy of the aforementioned warming interventions. Patients are selected for one of 3 arms. In Arm 1 the patient receives intraperitoneal chemotherapy warmed to body temperature. In Arm 2 the patient receives intraperitoneal chemotherapy at room temperature but will apply a heating pad to the abdomen. In Arm 3 the patient receives intraperitoneal chemotherapy at room temperature. The patient completes baseline European Organization for Treatment of Cancer Quality of Life C30 (EORTC QLQ-C30) and OV 28 (EORTC QLQ OV 28) forms prior to treatment and following each IP chemotherapy infusion. Descriptive statistics will be computed for all variables (including mean, standard deviation, median and range). T-tests will be used to assess differences between groups. Research is in progress, no preliminary findings available.en_GB
dc.date.available2011-10-27T12:09:09Z-
dc.date.issued2011-10-27en_GB
dc.date.accessioned2011-10-27T12:09:09Z-
dc.conference.date2007en_US
dc.conference.name32nd Annual Oncology Nursing Society Congressen_US
dc.conference.hostOncology Nursing Societyen_US
dc.conference.locationLas Vegas, Nevada, USAen_US
dc.description.noteThis is an abstract-only submission. If the author has submitted a full-text item based on this abstract, you may find it by browsing the Virginia Henderson Global Nursing e-Repository by author. If author contact information is available in this abstract, please feel free to contact him or her with your queries regarding this submission. Alternatively, please contact the conference host, journal, or publisher (according to the circumstance) for further details regarding this item. If a citation is listed in this record, the item has been published and is available via open-access avenues or a journal/database subscription. Contact your library for assistance in obtaining the as-published article.-
All Items in this repository are protected by copyright, with all rights reserved, unless otherwise indicated.